EN
中文 EN
Company News
Home >Newsroom >Company News
ALL
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
2013
2012
2007
2021.12.29
CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China
2021.12.23
Convidecia™ Phase III Results Published in The Lancet
2021.11.08
Indonesian Ambassador to China Visits CanSino SPH Biologics
2021.10.03
GLOBALink | Argentina uses Chinese CanSino COVID-19 vaccine to immunize working-class neighborhoods
2021.09.18
“Invisible Mask” for COVID Protection: Globally Innovative Inhaled Vaccine is Safer, More Effective and More Accessible
2021.09.06
Coronavirus Pandemic: Chinese developer shares efficacy of inhaled vaccines
2021.06.23
CanSinoBIO Announces Approval for Its Group A and Group C Meningococcal Conjugate Vaccine in China
2021.05.21
CanSinoBIO Receives EU GMP Certificate
2021.02.25
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine in China
2021.02.24
NMPA Accepts the Application for Conditional Marketing Authorization of CanSinoBIO’s COVID-19 Vaccine ConvideciaTM
1